Cite
Nabavi SM, Abolfazli R, Etemadrezaei A, et al. A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran. Iran J Pharm Res. 2019;18(3):1632-1638doi: 10.22037/ijpr.2019.14503.12441.
Nabavi, S. M., Abolfazli, R., Etemadrezaei, A., Hosseini, H., Moradi, N., Shahriari, S., Mehdipour, B., Shekarchi, B., & Soltanzadeh, A. (2019). A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran. Iranian journal of pharmaceutical research : IJPR, 18(3), 1632-1638. https://doi.org/10.22037/ijpr.2019.14503.12441
Nabavi, Seyed Massood, et al. "A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran." Iranian journal of pharmaceutical research : IJPR vol. 18,3 (2019): 1632-1638. doi: https://doi.org/10.22037/ijpr.2019.14503.12441
Nabavi SM, Abolfazli R, Etemadrezaei A, Hosseini H, Moradi N, Shahriari S, Mehdipour B, Shekarchi B, Soltanzadeh A. A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran. Iran J Pharm Res. 2019;18(3):1632-1638. doi: 10.22037/ijpr.2019.14503.12441. PMID: 32641970; PMCID: PMC6934945.
Copy
Download .nbib